{"date":"2025-09-24","count":14,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7784-2025-09-24-2350-1xyum4f","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-09-24","time":"23:50:09","subject":"本公司研發中新藥ABT-301獲得澳洲人體試驗倫理審查委員會同意進行Phase 1/2臨床試驗，並獲得澳洲藥物管理局備查。","clause":"第9款","fact_date":"2025-09-24","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-09-24 23:50，「本公司研發中新藥ABT-301獲得澳洲人體試驗倫理審查委員會同意進行Phase 1/2臨床試驗，並獲得澳洲藥物管理局備查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-09-24-2219-1bgempb","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-09-24","time":"22:19:39","subject":"本公司向美國食品藥物管理局及歐盟藥品管理局諮詢研發中產品EG1206A三期臨床試驗豁免得到正面回應，決議終止EG1206A三期臨床試驗計畫","clause":"第10款","fact_date":"2025-09-24","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-09-24 22:19，「本公司向美國食品藥物管理局及歐盟藥品管理局諮詢研發中產品EG1206A三期臨床試驗豁免得到正面回應，決議終止EG1206」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-09-24-2214-143yla1","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-09-24","time":"22:14:34","subject":"公告本公司新增背書保證金額達新臺幣三千萬元以上且達公司最近期財務報表淨值百分之五以上","clause":"第22款","fact_date":"2025-09-24","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-09-24 22:14，「公告本公司新增背書保證金額達新臺幣三千萬元以上且達公司最近期財務報表淨值百分之五以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-09-24-2212-1w8ls96","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-09-24","time":"22:12:30","subject":"本公司董事會決議發行國內第二次無擔保轉換公司債","clause":"第11款","fact_date":"2025-09-24","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-09-24 22:12，「本公司董事會決議發行國內第二次無擔保轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-09-24-2211-1banbn1","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-09-24","time":"22:11:16","subject":"本公司董事會決議辦理現金增資發行新股","clause":"第11款","fact_date":"2025-09-24","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-09-24 22:11，「本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-09-24-1958-1yijgnk","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-09-24","time":"19:58:42","subject":"公告本公司註銷收回限制員工權利新股辦理變更登記完成(更新主管機關核准減資及資本變更登記完成日期)","clause":"第36款","fact_date":"2025-09-24","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-09-24 19:58，「公告本公司註銷收回限制員工權利新股辦理變更登記完成(更新主管機關核准減資及資本變更登記完成日期)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-09-24-1906-rxx7eg","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-09-24","time":"19:06:14","subject":"公告本公司註銷收回限制員工權利新股辦理變更登記完成","clause":"第36款","fact_date":"2025-09-24","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-09-24 19:06，「公告本公司註銷收回限制員工權利新股辦理變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2025-09-24-1813-1powifi","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2025-09-24","time":"18:13:31","subject":"公告本公司通過ISO 13485醫療器材品質管理系統認證","clause":"第44款","fact_date":"2025-09-24","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2025-09-24 18:13，「公告本公司通過ISO 13485醫療器材品質管理系統認證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-09-24-1645-1yyikku","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-09-24","time":"16:45:13","subject":"代重要子公司意能生技股份有限公司公告現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購","clause":"第45款","fact_date":"2025-09-24","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-09-24 16:45，「代重要子公司意能生技股份有限公司公告現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-09-24-1639-nh563x","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-09-24","time":"16:39:36","subject":"公告本公司董事會決議放棄參與子公司意能生技股份有限公司之現金增資","clause":"第53款","fact_date":"2025-09-24","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-09-24 16:39，「公告本公司董事會決議放棄參與子公司意能生技股份有限公司之現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2025-09-24-1029-mjin9a","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2025-09-24","time":"10:29:56","subject":"媒體報導說明。","clause":"第26款","fact_date":"2025-09-24","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2025-09-24 10:29，「媒體報導說明。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-09-24-0057-diw7x6","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-09-24","time":"00:57:14","subject":"公告董事會決議通過孫公司Lotus Pharma ehf.解散清算","clause":"第51款","fact_date":"2025-09-23","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-09-24 00:57，「公告董事會決議通過孫公司Lotus Pharma ehf.解散清算」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-09-24-0056-10siy8s","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-09-24","time":"00:56:52","subject":"本公司透過子公司投資並取得New Alvogen Group Holding, Inc.全數股權","clause":"第20款","fact_date":"2025-09-23","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-09-24 00:56，「本公司透過子公司投資並取得New Alvogen Group Holding, Inc.全數股權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-09-24-0056-2u9j09","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-09-24","time":"00:56:05","subject":"公告本公司召開重大訊息記者會內容","clause":"第51款","fact_date":"2025-09-23","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-09-24 00:56，「公告本公司召開重大訊息記者會內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}